28
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Viral Vector Based Improvement of Optic Nerve Regeneration: Characterization of Individual Axons’ Growth Patterns and Synaptogenesis in a Visual Target

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Lack of axon growth ability in the central nervous system poses a major barrier to achieving functional connectivity after injury. Thus, a non-transgenic regenerative approach to reinnervating targets has important implications in clinical and research settings. Previous studies using knockout (KO) mice have demonstrated long distance axon regeneration. Using an optic nerve injury model, here we evaluate the efficacy of viral, RNAi and pharmacological approaches that target the PTEN and STAT3 pathways to improve long distance axon regeneration in wild type (WT) mice. Our data show that adeno-associated virus (AAV) expressing short hairpin RNA (shRNA) against PTEN (shPTEN) enhances retinal ganglion cell axon regeneration after crush injury. However, compared to the previous data in PTEN KO mice, AAV-shRNA results in a lesser degree of regeneration, likely due to incomplete gene silencing inherent to RNAi. In comparison, an extensive enhancement in regeneration is seen when AAV-shPTEN is coupled to AAV encoding ciliary neurotrophic factor (CNTF) and to a cyclic adenosine monophosphate (cAMP) analogue, allowing axons to travel long distances and reach their target. We apply whole tissue imaging that facilitates three-dimensional visualization of single regenerating axons and document heterogeneous terminal patterns in the targets. This shows that some axonal populations generate extensive arbors and make synapses with the target neurons. Collectively, we show a combinatorial viral RNAi and pharmacological strategy that improves long distance regeneration in WT animals and provide single fiber projection data that indicates a degree of preservation of target recognition.

          Related collections

          Most cited references45

          • Record: found
          • Abstract: found
          • Article: not found

          Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway.

          The failure of axons to regenerate is a major obstacle for functional recovery after central nervous system (CNS) injury. Removing extracellular inhibitory molecules results in limited axon regeneration in vivo. To test for the role of intrinsic impediments to axon regrowth, we analyzed cell growth control genes using a virus-assisted in vivo conditional knockout approach. Deletion of PTEN (phosphatase and tensin homolog), a negative regulator of the mammalian target of rapamycin (mTOR) pathway, in adult retinal ganglion cells (RGCs) promotes robust axon regeneration after optic nerve injury. In wild-type adult mice, the mTOR activity was suppressed and new protein synthesis was impaired in axotomized RGCs, which may contribute to the regeneration failure. Reactivating this pathway by conditional knockout of tuberous sclerosis complex 1, another negative regulator of the mTOR pathway, also leads to axon regeneration. Thus, our results suggest the manipulation of intrinsic growth control pathways as a therapeutic approach to promote axon regeneration after CNS injury.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Sustained axon regeneration induced by co-deletion of PTEN and SOCS3

            A formidable challenge in neural repair in the adult central nervous system (CNS) is the long distances that regenerating axons often need to travel in order to reconnect with their targets. Thus, a sustained capacity for axon regeneration is critical for achieving functional restoration. Although deletion of either Phosphatase and tensin homolog (PTEN), a negative regulator of mammalian target of rapamycin (mTOR), or suppressor of cytokine signaling 3 (SOCS3), a negative regulator of Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway, in adult retinal ganglion cells (RGCs) individually promoted significant optic nerve regeneration, such regrowth tapered off around two weeks after the crush injury 1,2 . Remarkably, we now find that simultaneous deletion of both PTEN and SOCS3 enables robust and sustained axon regeneration. We further show that PTEN and SOCS3 regulate two independent pathways that act synergistically to promote enhanced axon regeneration. Gene expression analyses suggest that double deletion not only results in the induction of many growth-related genes, but also allows RGCs to maintain the expression of a repertoire of genes at the physiological level after injury. Our results reveal concurrent activation of mTOR and STAT3 pathways as a key for sustaining long-distance axon regeneration in adult CNS, a crucial step toward functional recovery.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference.

              In the present study, the relationship between short interfering RNA (siRNA) sequence and RNA interference (RNAi) effect was extensively analyzed using 62 targets of four exogenous and two endogenous genes and three mammalian and Drosophila cells. We present the rules that may govern siRNA sequence preference and in accordance with which highly effective siRNAs essential for systematic mammalian functional genomics can be readily designed. These rules indicate that siRNAs which simultaneously satisfy all four of the following sequence conditions are capable of inducing highly effective gene silencing in mammalian cells: (i) A/U at the 5' end of the antisense strand; (ii) G/C at the 5' end of the sense strand; (iii) at least five A/U residues in the 5' terminal one-third of the antisense strand; and (iv) the absence of any GC stretch of more than 9 nt in length. siRNAs opposite in features with respect to the first three conditions give rise to little or no gene silencing in mammalian cells. Essentially the same rules for siRNA sequence preference were found applicable to DNA-based RNAi in mammalian cells and in ovo RNAi using chick embryos. In contrast to mammalian and chick cells, little siRNA sequence preference could be detected in Drosophila in vivo RNAi.
                Bookmark

                Author and article information

                Contributors
                Journal
                9421525
                8603
                Gene Ther
                Gene Ther.
                Gene therapy
                0969-7128
                1476-5462
                16 May 2015
                25 May 2015
                October 2015
                01 April 2016
                : 22
                : 10
                : 811-821
                Affiliations
                Miami Project to Cure Paralysis and Department of Neurosurgery, University of Miami Miller School of Medicine. Mailing address: Miami Project to Cure Paralysis, 1094 NW 14th Ter. RM 3-01, Miami, FL, 33136. Phone: (1) 305 243 2599, Fax: (1) 305 243 3921
                Miami Project to Cure Paralysis and Department of Neurosurgery, University of Miami Miller School of Medicine. Mailing address: Miami Project to Cure Paralysis, 1094 NW 14th Ter. RM 3-01, Miami, FL, 33136. Phone: (1) 305 243 2599, Fax: (1) 305 243 3921
                Miami Project to Cure Paralysis and Department of Neurosurgery, University of Miami Miller School of Medicine. Mailing address: Miami Project to Cure Paralysis, 1094 NW 14th Ter. RM 3-01, Miami, FL, 33136. Phone: (1) 305 243 2599, Fax: (1) 305 243 3921
                Department of Biomedical Sciences, Marquette University. Mailing address: Department of Biomedical Sciences, College of Health Sciences, Schroeder Complex, 429, Milwaukee, WI 53201-1881. Phone: 1 (414) 288-4532
                Miami Project to Cure Paralysis and Department of Neurosurgery, University of Miami Miller School of Medicine. Mailing address: Miami Project to Cure Paralysis, 1094 NW 14th Ter. RM 4-20, Miami, FL, 33136. Phone: (1) 305 243 2493, Fax: (1) 305 243 3921
                Author notes
                Correspondence should be addressed to: Kevin K. Park Miami Project to Cure Paralysis, University of Miami, Miller School of Medicine, Miami, FL, 33136, USA. Phone: (1) 305 243 2493, kpark@ 123456med.miami.edu
                Article
                NIHMS688138
                10.1038/gt.2015.51
                4600032
                26005861
                c16075a7-c86c-4737-976f-e78858eebcb7

                Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms

                History
                Categories
                Article

                Molecular medicine
                axon regeneration,retinal ganglion cell,pten,axon injury,axon guidance
                Molecular medicine
                axon regeneration, retinal ganglion cell, pten, axon injury, axon guidance

                Comments

                Comment on this article